HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Opana(®) ER induced thrombotic thrombocytopenic purpura.

Abstract
We present the case of a patient who developed thrombotic thrombocytopenic purpura (TTP) following intravenous injection of Opana(®) ER. TTP reemerged after three months of abstinence with Opana misuse. This case report brings awareness to the possibility of developing TTP in those who misuse Opana, which is a growing concern.
AuthorsNabil Kotbi, Bernadine Han, Duncan Cheng, Anna E Odom
JournalInternational medical case reports journal (Int Med Case Rep J) Vol. 8 Pg. 97-8 ( 2015) ISSN: 1179-142X [Print] New Zealand
PMID25995651 (Publication Type: Case Reports)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: